Literature DB >> 19165454

[Palliative care in patients with head and neck cancer].

Astrid Namjesky1.   

Abstract

Progressive cancer leads to loss of quality of life. This is particularly true for head and neck cancers as they dramatically affect the patients and in addition to this psychological burden cause a lot of physical disabilities. Patients struggle against retreat and helplessness of their environment, feel ostracized and not any longer being a human. In advanced diseases, surgery is not the first choice of treatment. Ostensible control of symptoms, care of relatives and notice of psychosocial facts are the most important therapeutic issues in these patients. They gain the greatest benefit from palliative care with good control of symptoms. This is highlighted by the following case reports.

Entities:  

Mesh:

Year:  2008        PMID: 19165454     DOI: 10.1007/s10354-008-0624-x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

1.  Antibacterial essential oils in malodorous cancer patients: clinical observations in 30 patients.

Authors:  P H Warnke; E Sherry; P A J Russo; Y Açil; J Wiltfang; S Sivananthan; M Sprengel; J C Roldàn; S Schubert; J P Bredee; I N G Springer
Journal:  Phytomedicine       Date:  2005-11-02       Impact factor: 5.340

2.  [Chronic pain therapy for patients with head and neck tumors].

Authors:  A Walz; B Haberland; B Wollenberg; C Bausewein
Journal:  HNO       Date:  2006-10       Impact factor: 1.284

Review 3.  Management of salivary flow in head and neck cancer patients--a systematic review.

Authors:  Steven R Bomeli; Shaun C Desai; Jonas T Johnson; Rohan R Walvekar
Journal:  Oral Oncol       Date:  2008-05-16       Impact factor: 5.337

4.  Palliative care for patients with head and neck cancer: "I would like a quick return to a normal lifestyle".

Authors:  Nathan E Goldstein; Eric Genden; R Sean Morrison
Journal:  JAMA       Date:  2008-04-16       Impact factor: 56.272

5.  Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome.

Authors:  E Babin; E Sigston; M Hitier; D Dehesdin; J P Marie; O Choussy
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-11       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.